Children with IgA vasculitis who present with severe skin manifestations may be at higher risk for relapse and should be followed up for at least 1 year.

Ocrevus (ocrelizumab) and Tysabri (natalizumab) appear equally effective at controlling relapses and MS progression, a study finds.

Treatment with fenebrutinib significantly reduced the annualized relapse rate by 51% compared with teriflunomide. Topline data were announced from a second phase 3 trial evaluating fenebrutinib, an ...

Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...

New therapies for multiple myeloma are dramatically improving prognosis and extending survival. Better disease control is prolonging remission and allowing patients to live without any sign of disease ...

Wearable trackers could even detect the probability of a relapse weeks or months before it occurs. Up to around 60% of people with MDD will experience at least one relapse episode in their lifetime.

Could a smart watch act as an early-warning system for depression relapse? New research from McMaster University suggests that disruptions in a person's sleep and daily activity routine, as detected ...

In 2013, Jowita Bydlowska released her groundbreaking memoir Drunk Mom, an unflinching account of how new motherhood sparked her full-blown return to alcoholism. The book was a vital addition to ...